Final answer:
The specific antidepressant the FDA advises against using during pregnancy is not provided, but the use of SSRIs during pregnancy requires careful consideration and is determined on a case-by-case basis, with careful weighing of the associated risks and benefits.
Step-by-step explanation:
The ONLY antidepressant the FDA advises against using during pregnancy is not explicitly stated within the provided information. However, it is known that certain antidepressants, particularly Selective Serotonin Reuptake Inhibitors (SSRIs), are generally evaluated for safety during pregnancy, and decisions regarding their use must be made on a case-by-case basis in consultation with healthcare providers. SSRIs like fluoxetine (Prozac), sertraline (Zoloft), and others have been widely prescribed and have a varying risk profile during pregnancy. It's important to discuss with a doctor or healthcare provider the possible risks and benefits of SSRI use during pregnancy.
While SSRIs are widely used due to their high toxic dose and relatively mild side effects, they must be used cautiously during pregnancy. If such medications are necessary for the health of the mother, risks and benefits must be weighed, as untreated depression itself can pose risks to both the mother and the developing fetus. The use of antidepressants such as fluoxetine is associated with increased serotonin levels in the central nervous system and can be beneficial in treating depression and associated disorders, including obsessive-compulsive disorders.